Portal de investigación
Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Londoño MC
- Riveiro-Barciela M
- Ahumada A
- Muñoz-Gómez R
- Roget M
- Devesa-Medina MJ
- Serra MÁ
- Navascués CA
- Baliellas C
- Aldamiz-Echevarría T
- Gutiérrez ML
- Polo-Lorduy B
- Carmona I
- Bonet L
- García-Samaniego J
- Jiménez-Pérez M
- Morán-Sánchez S
- Castro Á
- Gea-Rodríguez F
- Martín-Granizo I
- Montes ML
- Morano L
- Castaño MA
- de Los Santos I
- Laguno M
- Losa JE
- de Álvaro C
- Manzanares A
- Mallolas J
- Barril G
- González-Parra E
- García-Buey L
Grupos
Abstract
Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015.
Datos de la publicación
- ISSN/ISSNe:
- 1932-6203, 1932-6203
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 31550267
- Factor de Impacto:
- 1,023 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
PLoS One PUBLIC LIBRARY SCIENCE
Citas Recibidas en Web of Science: 7
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
Londoño MC,Riveiro M,Ahumada A,Muñoz R,Roget M,Devesa MJ,Serra MÁ,Navascués CA,Baliellas C,Aldamiz T,Gutiérrez ML,Polo B,Carmona I,BENLLOCH S,Bonet L,García J,Jiménez M,Morán S,Castro Á,DELGADO M,Gea F,Martín I,Montes ML,Morano L,Castaño MA,de Los Santos I,Laguno M,Losa JE,MONTERO M,RIVERO A,de Álvaro C,Manzanares A,Mallolas J,Barril G,González E,García L. Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study. PLoS One. 2019. 14. (9):e0221567. IF:2,740. (2).